Autonomic Control in Diabetes: Translational Perspective

Jeffrey Goldberger

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

Diabetes and Coronary Disease

Scottsdale Interventional Forum 2017

Effect of Sacubitril/Valsartan on Glycemic Control in Patients with …

Jelena Seferovic

Diabetic Management to Reduce CV Events

Complex Coronary Valvular and Vascular Cases Conference

Lipotoxicity and NAFLD: The Overlooked Complication of T2DM

World Congress Insulin Resistance and Cardiovascular Disease

Cellular Mechanisms for Lipid Induced Muscle Insulin Resistance

World Congress Insulin Resistance and Cardiovascular Disease

Reviewing the Cardiovascular Comorbidities in Type 2 Diabetes

Cardiometabolic Health Congress (CMHC)

J. Skyler

Interpreting New Antihyperglycemic Agents

Cardiometabolic Health Congress (CMHC)

B. Scirica

Access to Medications and Healthcare in High Risk Special Populations

Cardiometabolic Health Congress (CMHC)

K. Ferdinand

Paradigm Shifts: Understanding and Applying the Latest Lipid Guideli…

Advances in Cardiovascular Disease Prevention

A. Freeman

Lifestyle Management to Reduce Cardiovascular Risk

Advances in Cardiovascular Disease Prevention

A. Freeman

Changing Landscape of CV Treatment in Type 2 Diabetes

Cardiology Fiesta 2018

Effect of Diabetes Medications on the Kidney (and Heart)

UC Davis Health Diabetes and Endocrinology Symposium

S. Ananthakrishnan

Preventive Cardiology in the Diabetic Patient

3rd National Conference On Prevention Of Diabetes

J. Baer

Prevention of CVD and HF in Type 2 Diabetics

Northwestern Medicine: 13th Annual Heart Failure Symposium

D. Lloyd-Jones

Results of REDUCE-IT

National Lipid Association

M. Miller

What Should the Clinical Lipidologist Do with The REDUCE-IT Results?

National Lipid Association

P. Jones

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Developing a Lipid Clinic in an Academic Setting

National Lipid Association